10 Body Type Acupuncture Clinic Los Angeles, CA - 90038

10 Body Type Acupuncture Clinic is categorized under Acupuncturists in Los Angeles, CA and active since 2011.

10 Body Type Acupuncture Clinic was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Acupuncturists business, which does work in the B2C market, and is classified as a Acupuncturists, under code number by the NAICS.

If you are seeking more information, feel free to contact Christina Choe at the company’s headquarters by writing to 5770 Melrose Ave #207 & 208, Los Angeles, California CA 90038 or by phoning (213) 675-0111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: 10 Body Type Acupuncture Clinic
Contact Person: Christina Choe
Address: 5770 Melrose Ave #207 & 208, Los Angeles, California 90038
Phone Number: (213) 675-0111
Website Address: 10bodytypeclinic.com
Annual Revenue (USD): $50.000 to $99.999
Founded: 2011
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Acupuncturists
Share This Business:

10 Body Type Acupuncture Clinic was started in 2011 to provide professional Acupuncturists under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Christina Choe for inquiries that concern 10 Body Type Acupuncture Clinic by calling the company number (213) 675-0111, as your correspondence is most welcome. Additionally, the physical location of the headquarters of 10 Body Type Acupuncture Clinic can be found at the coordinates 37.7167,13.4333 as well as the street address 5770 Melrose Ave #207 & 208 in Los Angeles, California 90038.

For its online presence, you may visit 10 Body Type Acupuncture Clinic’s website at 10bodytypeclinic.com and engage with its social media outlets through on Twitter and on Facebook.